{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:22:52Z","timestamp":1787062972630,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":57,"publisher":"Springer New York","isbn-type":[{"value":"9781461447252","type":"print"},{"value":"9781461447269","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-4614-4726-9_15","type":"book-chapter","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T16:04:17Z","timestamp":1355155457000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Mycetoma Caused by Madurella mycetomatis: A Completely Neglected Medico-social Dilemma"],"prefix":"10.1007","author":[{"given":"Alex","family":"Van Belkum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Fahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy W.J.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"issue":"9","key":"15_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S1473-3099(04)01131-4","volume":"4","author":"AO Ahmed","year":"2004","unstructured":"Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A (2004) Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 4(9):566\u2013574","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"15_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0733-8635(05)70329-6","volume":"14","author":"MR McGinnis","year":"1996","unstructured":"McGinnis MR (1996) Mycetoma. Dermatol Clin 14(1):97\u2013104","journal-title":"Dermatol Clin"},{"issue":"11","key":"15_CR3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1365-4632.2010.04610.x","volume":"49","author":"S Padhi","year":"2010","unstructured":"Padhi S, Uppin SG, Uppin MS, Umabala P, Challa S, Laxmi V, Prasad VB (2010) Mycetoma in South India: retrospective analysis of 13 cases and description of two cases caused by unusual pathogens: Neoscytalidium dimidiatum and Aspergillus flavus. Int J Dermatol 49(11):1289\u20131296","journal-title":"Int J Dermatol"},{"issue":"4","key":"15_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/0970-9371.73297","volume":"27","author":"N Afroz","year":"2010","unstructured":"Afroz N, Khan N, Siddiqui FA, Rizvi M (2010) Eumycetoma versus actinomycetoma: diagnosis on cytology. J Cytol 27(4):133\u2013135","journal-title":"J Cytol"},{"issue":"1","key":"15_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/02681218780000051","volume":"25","author":"DB Wethered","year":"1987","unstructured":"Wethered DB, Markey MA, Hay RJ, Mahgoub ES, Gumaa SA (1987) Ultrastructural and immunogenic changes in the formation of mycetoma grains. J Med Vet Mycol 25(1):39\u201346","journal-title":"J Med Vet Mycol"},{"issue":"3","key":"15_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1128\/JCM.40.3.1031-1036.2002","volume":"40","author":"A Ahmed","year":"2002","unstructured":"Ahmed A, Adelmann D, Fahal A, Verbrugh H, van Belkum A, de Hoog S (2002) Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J Clin Microbiol 40(3):1031\u20131036","journal-title":"J Clin Microbiol"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JCM.36.3.850-851.1998","volume":"36","author":"AO Ahmed","year":"1998","unstructured":"Ahmed AO, Abugroun E, Fahal AH, Zijlstra EE, van Belkum A, Verbrugh HA (1998) Unexpected high prevalence of secondary bacterial infection in patients with mycetoma. J Clin Microbiol 36:850\u2013851","journal-title":"J Clin Microbiol"},{"issue":"1","key":"15_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2230.2008.03028.x","volume":"34","author":"M Ameen","year":"2009","unstructured":"Ameen M, Arenas R (2009) Developments in the management of mycetomas. Clin Exp Dermatol 34(1):1\u20137","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"15_CR9","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1128\/JCM.41.12.5813-5816.2003","volume":"41","author":"AO Ahmed","year":"2003","unstructured":"Ahmed AO, Desplaces N, Leonard P, Goldstein F, De Hoog S, Verbrugh H, van Belkum A (2003) Molecular detection and identification of agents of eumycetoma: detailed report of two cases. J Clin Microbiol 41(12):5813\u20135816","journal-title":"J Clin Microbiol"},{"issue":"1","key":"15_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/02681219580000041","volume":"33","author":"AH Fahal","year":"1995","unstructured":"Fahal AH, el Toum EA, el Hassan AM, Mahgoub ES, Gumaa SA (1995) The host tissue reaction to Madurella mycetomatis: new classification. J Med Vet Mycol 33(1):15\u201317","journal-title":"J Med Vet Mycol"},{"issue":"12","key":"15_CR11","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1517\/14656566.9.12.2077","volume":"9","author":"M Ameen","year":"2008","unstructured":"Ameen M, Arenas R (2008) Emerging therapeutic regimes for the management of mycetomas. Expert Opin Pharmacother 9(12):2077\u20132085","journal-title":"Expert Opin Pharmacother"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0035-9203(84)90126-3","volume":"78","author":"ES Mahgoub","year":"1984","unstructured":"Mahgoub ES, Gumaa SA (1984) Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg 78:376\u2013379","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"15_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.trstmh.2010.11.008","volume":"105","author":"AH Fahal","year":"2011","unstructured":"Fahal AH, Rahman IA, El-Hassan AM, Rahman ME, Zijlstra EE (2011) The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg 105(3):127\u2013132","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"15_CR14","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1128\/AAC.48.7.2742-2746.2004","volume":"48","author":"AO Ahmed","year":"2004","unstructured":"Ahmed AO, van de Sande WW, van Vianen W, van Belkum A, Fahal AH, Verbrugh HA, Bakker-Woudenberg IA (2004) In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-base 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother 48(7):2742\u20132746","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"15_CR15","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1128\/AAC.49.4.1364-1368.2005","volume":"49","author":"WW van de Sande","year":"2005","unstructured":"van de Sande WW, Luijendijk A, Ahmed AO, Bakker-Woudenberg IA, van Belkum A (2005) Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- ((phenylamino)carbonyl)-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob Agents Chemother 49(4):1364\u20131368","journal-title":"Antimicrob Agents Chemother"},{"issue":"3\u20134","key":"15_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1439-0507.2004.00964.x","volume":"47","author":"GS de Hoog","year":"2004","unstructured":"de Hoog GS, Adelmann D, Ahmed AO, van Belkum A (2004) Phylogeny and typification of Madurella mycetomatis, with a comparison of other agents of eumycetoma. Mycoses 47(3\u20134):121\u2013130","journal-title":"Mycoses"},{"issue":"10","key":"15_CR17","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1128\/JCM.00862-06","volume":"44","author":"M Desnos-Ollivier","year":"2006","unstructured":"Desnos-Ollivier M, Bretagne S, Dromer F, Lortholary O, Dannaoui E (2006) Molecular identification of black-grain mycetoma agents. J Clin Microbiol 44(10):3517\u20133523","journal-title":"J Clin Microbiol"},{"issue":"4","key":"15_CR18","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1128\/JCM.02425-10","volume":"49","author":"AA Padhye","year":"2011","unstructured":"Padhye AA, Salkin IF (2011) Madurella pseudomycetomatis: an invalidly published name. J Clin Microbiol 49(4):1703","journal-title":"J Clin Microbiol"},{"issue":"10","key":"15_CR19","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1128\/JCM.37.10.3175-3178.1999","volume":"37","author":"AO Ahmed","year":"1999","unstructured":"Ahmed AO, Mukhtar MM, Kools-Sijmons M, Fahal AH, de Hoog S, van den Ende BG, Zijlstra EE, Verbrugh H, Abugroun ES, Elhassan AM, van Belkum A (1999) Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J Clin Microbiol 37(10):3175\u20133178","journal-title":"J Clin Microbiol"},{"issue":"10","key":"15_CR20","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1128\/JCM.41.10.4537-4541.2003","volume":"41","author":"A Ahmed","year":"2003","unstructured":"Ahmed A, van de Sande W, Verbrugh H, Fahal A, van Belkum A (2003) Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J Clin Microbiol 41(10):4537\u20134541","journal-title":"J Clin Microbiol"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.trstmh.2009.07.016","volume":"104","author":"AH Fahal","year":"2010","unstructured":"Fahal AH, Abu S (2010) Mycetoma in children. Trans R Soc Trop Med Hyg 104:107\u2013112","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"15_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0035-9203(87)90252-5","volume":"81","author":"MA Yousif","year":"1987","unstructured":"Yousif MA, Hay RJ (1987) Leucocyte chemotaxis to mycetoma agents--the effect of the antifungal drugs griseofulvin and ketoconazole. Trans R Soc Trop Med Hyg 81(2):319\u2013321","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"15_CR23","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.4049\/jimmunol.177.3.1997","volume":"177","author":"WW van de Sande","year":"2006","unstructured":"van de Sande WW, Janse DJ, Hira V, Goedhart H, van der Zee R, Ahmed AO, Ott A, Verbrugh H, van Belkum A (2006) Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression. J Immunol 177(3):1997\u20132005","journal-title":"J Immunol"},{"issue":"1\u20132","key":"15_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1439-0507.1991.tb00614.x","volume":"34","author":"F Zaini","year":"1991","unstructured":"Zaini F, Moore MK, Hathi D, Hay RJ, Noble WC (1991) The antigenic composition and protein profiles of eumycetoma agents. Mycoses 34(1\u20132):19\u201328","journal-title":"Mycoses"},{"issue":"5","key":"15_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/02681218980000411","volume":"27","author":"H Romero","year":"1989","unstructured":"Romero H, Mackenzie DW (1989) Studies on antigens from agents causing black grain eumycetoma. J Med Vet Mycol 27(5):303\u2013311","journal-title":"J Med Vet Mycol"},{"issue":"5","key":"15_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.otohns.2003.07.014","volume":"130","author":"RS Jiang","year":"2004","unstructured":"Jiang RS, Hsu CY (2004) Serum immunoglobulins and IgG subclass levels in sinus mycetoma. Otolaryngol Head Neck Surg 130(5):563\u2013566","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"15_CR27","first-page":"31","volume":"14","author":"MJ Araujo","year":"1997","unstructured":"Araujo MJ, Casta\u00f1eda E (1997) Madurella mycetomatis antigen for the serodiagnosis of mycetoma. Rev Iberoam Micol 14(1):31\u201335","journal-title":"Rev Iberoam Micol"},{"key":"15_CR28","doi-asserted-by":"crossref","unstructured":"de Klerk N, de Vogel C, Fahal A, van Belkum A, van de Sande WW (2011) Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis. Med Mycol (Epub ahead of print)","DOI":"10.3109\/13693786.2011.593005"},{"issue":"1","key":"15_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00436415","volume":"115","author":"C Rajendran","year":"1991","unstructured":"Rajendran C, Baby A, Kumari S, Verghese T (1991) An evaluation of straw-extract agar media for the growth and sporulation of Madurella mycetomatis. Mycopathologia 115(1):9\u201312","journal-title":"Mycopathologia"},{"issue":"9","key":"15_CR30","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1128\/JCM.43.9.4349-4356.2005","volume":"43","author":"WW van de Sande","year":"2005","unstructured":"van de Sande WW, Gorkink R, Simons G, Ott A, Ahmed AO, Verbrugh H, van Belkum A (2005) Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size. J Clin Microbiol 43(9):4349\u20134356","journal-title":"J Clin Microbiol"},{"issue":"21","key":"15_CR31","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1093\/nar\/23.21.4407","volume":"23","author":"P Vos","year":"1995","unstructured":"Vos P, Hogers R, Bleeker M, Reijans M, van de Lee T, Hornes M, Frijters A, Pot J, Peleman J, Kuiper M et al (1995) AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res 23(21):4407\u20134414","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"15_CR32","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1128\/AAC.01045-10","volume":"55","author":"A van Belkum","year":"2011","unstructured":"van Belkum A, Fahal AH, van de Sande WW (2011) In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine. Antimicrob Agents Chemother 55(4):1771\u20131773","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"15_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-4632.2004.02392.x","volume":"45","author":"B N\u2019diaye","year":"2006","unstructured":"N\u2019diaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R (2006) Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 45(2):154\u2013157","journal-title":"Int J Dermatol"},{"issue":"6","key":"15_CR34","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1128\/AAC.01546-09","volume":"54","author":"WW van de Sande","year":"2010","unstructured":"van de Sande WW, Fahal AH, Bakker-Woudenberg IA, van Belkum A (2010) Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents. Antimicrob Agents Chemother 54(6):2738\u20132740","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"15_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0035-9203(84)90126-3","volume":"78","author":"ES Mahgoub","year":"1984","unstructured":"Mahgoub ES, Gumaa SA (1984) Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg 78(3):376\u2013379","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"15_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1590\/S0036-46652005000600006","volume":"47","author":"R Negroni","year":"2005","unstructured":"Negroni R, Tob\u00f3n A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A (2005) Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47(6):339\u2013346","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"3","key":"15_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/jac\/dkl526","volume":"59","author":"WW van de Sande","year":"2007","unstructured":"van de Sande WW, Fahal AH, Riley TV, Verbrugh H, van Belkum A (2007) In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. J Antimicrob Chemother 59(3):553\u2013555","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"15_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2001.tb10724.x","volume":"201","author":"TM Wassenaar","year":"2001","unstructured":"Wassenaar TM, Gaastra W (2001) Bacterial virulence: can we draw the line? FEMS Microbiol Lett 201(1):1\u20137","journal-title":"FEMS Microbiol Lett"},{"issue":"3","key":"15_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2133.1974.tb12899.x","volume":"91","author":"GH Findlay","year":"1974","unstructured":"Findlay GH, Vismer HF (1974) Black grain mycetoma. A study of the chemistry, formation and significance of the tissue grain in Madurella mycetomi infection. Br J Dermatol 91(3):297\u2013303","journal-title":"Br J Dermatol"},{"issue":"4","key":"15_CR40","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1128\/CMR.00019-10","volume":"23","author":"SG Revankar","year":"2010","unstructured":"Revankar SG, Sutton DA (2010) Melanized fungi in human disease. Clin Microbiol Rev 23(4):884\u2013928","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"15_CR41","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.micinf.2007.05.015","volume":"9","author":"WW van de Sande","year":"2007","unstructured":"van de Sande WW, de Kat J, Coppens J, Ahmed AO, Fahal A, Verbrugh H, van Belkum A (2007) Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infect 9(9):1114\u20131123","journal-title":"Microbes Infect"},{"issue":"12","key":"15_CR42","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1128\/AAC.00376-07","volume":"51","author":"LR Martinez","year":"2007","unstructured":"Martinez LR, Ntiamoah P, G\u00e1cser A, Casadevall A, Nosanchuk JD (2007) Voriconazole inhibits melanization in Cryptococcus neoformans. Antimicrob Agents Chemother 51(12):4396\u20134400","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"15_CR43","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.molimm.2007.06.002","volume":"45","author":"R Rid","year":"2008","unstructured":"Rid R, Simon-Nobbe B, Langdon J, Holler C, Wally V, P\u00f6ll V, Ebner C, Hemmer W, Hawranek T, Lang R, Richter K, MacDonald S, Rinnerthaler M, Laun P, Mari A, Breitenbach M (2008) Cladosporium herbarum translationally controlled tumor protein (TCTP) is an IgE-binding antigen and is associated with disease severity. Mol Immunol 45(2):406\u2013418","journal-title":"Mol Immunol"},{"issue":"5","key":"15_CR44","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.4049\/jimmunol.179.5.3065","volume":"179","author":"WW van de Sande","year":"2007","unstructured":"van de Sande WW, Fahal A, Verbrugh H, van Belkum A (2007) Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. J Immunol 179(5):3065\u20133074","journal-title":"J Immunol"},{"issue":"1","key":"15_CR45","first-page":"48","volume":"70","author":"ES Mahgoub","year":"1977","unstructured":"Mahgoub ES, Gumaa SA, El Hassan AM (1977) Immunological status of mycetoma patients. Bull Soc Pathol Exot Filiales 70(1):48\u201354","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"3","key":"15_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/00362177885380281","volume":"16","author":"ES Mahgoub","year":"1978","unstructured":"Mahgoub ES (1978) Experimental infection of athymic nude New Zealand mice, nu nu strain with mycetoma agents. Sabouraudia 16(3):211\u2013216","journal-title":"Sabouraudia"},{"issue":"3","key":"15_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0021-9975(81)90003-7","volume":"91","author":"SA Gumaa","year":"1981","unstructured":"Gumaa SA, Abu-Samra MT (1981) Experimental mycetoma infection in the goat. J Comp Pathol 91(3):341\u2013346","journal-title":"J Comp Pathol"},{"issue":"1","key":"15_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF00437283","volume":"91","author":"K Nishimura","year":"1985","unstructured":"Nishimura K, Miyaji M (1985) Pathogenicity of Exophiala jeanselmei for ddY mice. Mycopathologia 91(1):29\u201333","journal-title":"Mycopathologia"},{"issue":"1","key":"15_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0928-8244(03)00096-8","volume":"37","author":"AO Ahmed","year":"2003","unstructured":"Ahmed AO, van Vianen W, ten Kate MT, van de Sande WW, van Belkum A, Fahal AH, Verbrugh HA, Bakker-Woudenberg IA (2003) A murine model of Madurella mycetomatis eumycetoma. FEMS Immunol Med Microbiol 37(1):29\u201336","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"15_CR50","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1378\/chest.122.3.886","volume":"122","author":"AK Greenberg","year":"2002","unstructured":"Greenberg AK, Knapp J, Rom WN, Addrizzo-Harris DJ (2002) Clinical presentation of pulmonary mycetoma in HIV-infected patients. Chest 122(3):886\u2013892","journal-title":"Chest"},{"issue":"7","key":"15_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3109\/13693781003636680","volume":"48","author":"WW van de Sande","year":"2010","unstructured":"van de Sande WW, Fahal A, Tavakol M, van Belkum A (2010) Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards Madurella mycetomatis-induced mycetoma susceptibility. Med Mycol 48(7):959\u2013968","journal-title":"Med Mycol"},{"issue":"Suppl 1","key":"15_CR52","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1007\/BF02680000","volume":"161","author":"TW Kuijpers","year":"2002","unstructured":"Kuijpers TW (2002) Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death. Eur J Pediatr 161(Suppl 1):S75\u201382","journal-title":"Eur J Pediatr"},{"issue":"2","key":"15_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/bfgp\/elq037","volume":"10","author":"MJ Newport","year":"2011","unstructured":"Newport MJ, Finan C (2011) Genome-wide association studies and susceptibility to infectious diseases. Brief Funct Genomics 10(2):98\u2013107","journal-title":"Brief Funct Genomics"},{"issue":"4","key":"15_CR54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.5732\/cjc.011.10075","volume":"30","author":"YY Shugart","year":"2011","unstructured":"Shugart YY, Wang Y, Jia WH, Zeng YX (2011) GWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseases. Chin J Cancer 30(4):226\u2013230","journal-title":"Chin J Cancer"},{"issue":"3","key":"15_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jgg.2011.02.003","volume":"38","author":"J Zhang","year":"2011","unstructured":"Zhang J, Chiodini R, Badr A, Zhang G (2011) The impact of next-generation sequencing on genomics. J Genet Genomics 38(3):95\u2013109","journal-title":"J Genet Genomics"},{"issue":"2","key":"15_CR56","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1399-0004.2011.01706.x","volume":"80","author":"P Ostergaard","year":"2011","unstructured":"Ostergaard P, Simpson MA, Jeffery S (2011) Massively parallel sequencing and identification of genes for primary lymphoedema: a perfect fit. Clin Genet 80(2):110\u2013116","journal-title":"Clin Genet"},{"issue":"12","key":"15_CR57","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.705","volume":"42","author":"G Morelli","year":"2010","unstructured":"Morelli G, Song Y, Mazzoni CJ, Eppinger M, Roumagnac P, Wagner DM, Feldkamp M, Kusecek B, Vogler AJ, Li Y, Cui Y, Thomson NR, Jombart T, Leblois R, Lichtner P, Rahalison L, Petersen JM, Balloux F, Keim P, Wirth T, Ravel J, Yang R, Carniel E, Achtman M (2010) Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet 42(12):1140\u20131143","journal-title":"Nat Genet"}],"container-title":["Advances in Experimental Medicine and Biology","Hot Topics in Infection and Immunity in Children IX"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-4726-9_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T23:48:16Z","timestamp":1714693696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-4726-9_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"ISBN":["9781461447252","9781461447269"],"references-count":57,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-4726-9_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]},"assertion":[{"value":"11 December 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}